Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
California Snaps Up Civica For Biosimilar Insulin Initiative
Plus Brand Insulins Drop Prices Following Landmark Lilly Decision
Mar 23 2023
•
By
Chloe Kent
Governor Newsom says California will now pursue manufacturing its own naloxone • Source: Gavin Newsom
More from Biosimilars
More from Products
